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Avian influenza viruses (AIVs) belong to the Orthomyxo-
viridae family andare classified according to their haemagglutinin
(HA) and neuraminidase (NA) proteins. On the basis of
their ability to cause disease in poultry, avian influenza viruses
are further classified as low pathogenic (LPAI) and highly
pathogenic (HPAI), both causing severe financial losses to the
poultry industry. Poultry also act as a reservoir for AIVs and
thus provide an environment for the emergence of novel AIV
subtypes, whichmay present a threat to human health, through
the processes of recombination and re-assortment. Hence, im-
proved understanding of influenza virus infections in chickensPC, Antigen presenting
totoxic T lymphocytes;
inia virus Ankara; CKC,
y Group, Avian Viral
Laboratory, Newbury,
(C. Butter).
.V. This is an open access articis an important aspect of developing new control measures,
including vaccines for use in poultry. Improved control of in-
fluenza in chickens will protect the poultry industry and reduce
the risk of zoonotic transfer to humans.
Although influenza viruses are endemic in avian species
(Stech et al., 2009) understanding of influenza-specific cellular
responses is more limited in chickens than in humans or mice;
until recently a paucity of reagents and techniques has im-
peded a comprehensive study in birds. Although most studies
of host responses to influenza infection or vaccination in birds
have focused on the production of neutralizing antibodies, it
is clear that cell mediated immunity (CMI) is also relevant
(Suarez and Schultz-Cherry, 2000). The principal route for the
presentation of viral antigenic peptides involves the major
histocompatibility complex I (MHC I) pathway and results in
antigen presentation to CD8+ T cells (Subbarao and Joseph,
2007). In birds and mammals, influenza-specific CD8+ cyto-
toxic cells become activated and produce IFNγ during infection
in response to the engagement of their T cell receptors with
influenza-derived peptides in the context of MHCI on the
surface of antigen presenting cells (APC) (Rock et al., 1990;le under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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and Joseph, 2007). Cytotoxic T cell responses can be generated
against a variety of influenza proteins including surface asso-
ciated HA and NA antigens as well as internal proteins such as
matrix protein (M1) and nucleoprotein (NP). These CD8+ T cell
responses contribute to the control of influenza virus replica-
tion within cells, thereby enabling viral clearance and limiting
viral spread (Suarez and Schultz-Cherry, 2000; Kwon et al.,
2008). A suppression of these responses may contribute to
high and disseminated viral replication in chickens, contribut-
ing to the pathogenicity of LPAI viruses (Kwon et al., 2008).
Enhancement of CTL responses (principally against the most
conserved epitopes) has thus become the aim of vaccines
designed to produce heterosubtypic immunity to influenza in
humans (Berthoud et al., 2011) and chickens (Boyd et al.,
2012).
A number of techniques and reagents are currently in use
for the study of T cell responses in poultry. These include the
measurement of antigen specific proliferation by flow cytom-
etry (Dalgaard et al., 2010) intracellular cytokine staining
(De Boever et al., 2010), measurement of IFNγ production by
Enzyme-Linked Immunosorbent Assay (ELISA) (Ariaans et al.,
2009; Rauw et al., 2011) and Enzyme-Linked Immunosorbent
Spot (ELISpot) assay (Ariaans et al., 2008, 2009). CTL responses
to infectious bronchitis virus have previously been monitored
using MHC matched chicken kidney cells (CKC) serving as
antigen presenting cells (APC) (Seo and Collisson, 1997).
Through the use of MHC matched infected cells as surrogate
APC, the measurement of chicken IFNγ responses against
whole influenza virus or viral proteins has been achieved using
an indirect method based on the ability of IFNγ to activate the
HD11 macrophage cell line (Gobel et al., 2003; Singh et al.,
2010a,b).
Peptides are often used to study antigen specific responses,
and this method has been applied successfully in birds
(Haghighi et al., 2009; Reemers et al., 2012). While the use of
peptide libraries to identify influenza antigen specific responses
can be exquisitely informative, it also has his limitations. The
cost of peptide libraries can be prohibitive for many labs, even
before technical considerations. The use of a library of predicted
binding peptides excludes epitopes that are not predicted due
to an incomplete understanding of the binding motifs of
chicken class I MHC. This may be particularly challenging with
haplotypes such as B21 that has a highly promiscuous motif
(Koch et al., 2007). Although peptide length and motif can give
an indication of which group of cells responds, this does not
provide definitive information regarding the phenotypic iden-
tification of effector T cells (CD4 versus CD8), and there are no
significant data regarding processes such as cross presentation
in poultry model, rendering interpretation of peptide data
difficult. In addition, techniques such as intracellular staining
are technically challenging, requiring many manipulations of
the cells. ELISpot, while sensitive, provides no information as
to the effector cell phenotype unless the responding cells are
sorted prior to plating. This is also true for the HD11 activation
method, which requires culture and stimulation of HD11 as an
extra step.
In the present study we set out to develop a method to
preferentially detect CD8 T cell responses. We hypothesized
that by infecting cells which only express class I MHCwith AIVs
and culturing these with splenocytes from infected birds wewould potentiate detection of influenza specific CD8+ T cells.
We first derived a chicken kidney cell line from inbred chickens
MHC matched to our experimental cohort, tested that the
CKC expressed MHCI but not MHCII, then infected them with
influenza virus. After irradiation these cells were co-cultured
in ELISpots with MHC matched splenocytes either from
chickens exposed to influenza virus or from vaccinated
chickens. In both experimental scenarios we were able to
demonstrate the presence of antigen specific T cells. We also
demonstrated by flow cytometry that the IFNγ producing cells
were principally CD8positive. The assaywas reproducible,with
high sensitivity and low background noise, and will be a useful
tool in the analysis of CD8 T cell responses.2. Material and methods
2.1. Animals
Inbred lines of White Leghorn chickens, Line O (haplotype
B21) or Line 15 (B15) (Miller et al., 2004), were produced and
maintained at the Pirbright Institute (Compton, UK) in specific
pathogen-free (SPF) conditions and fed ad libitum. For infec-
tion studies birds were housed in self-contained BioFlex® B50
Rigid Body Poultry isolators (Bell Isolation Systems). Animal
procedures were carried out in accordance with local ethical
review and UKHomeOffice requirements (HomeOffice, 1986).2.2. Viral stocks
LPAI virus (A/Turkey/England/1977/H7N7) was grown in
embryonated chicken eggs using standard methods described
elsewhere (World Health Organization. Dept. of Epidemic and
Pandemic Alert and Response., 2002). Viral titer was estimated
by plaque assay on Madin-Darby canine kidney (MDCK) cells,
using standard techniques (Gaush and Smith, 1968).
Virus was inactivated in a final concentration of 0.094%
β-propiolactone (ACROS Organics, Geel, Belgium), as described
previously (Jonges et al., 2010) and aliquots were stored at
−80 °C until its use. Inactivation was verified by the absence
of plaques on MDCK cells. Recombinant Fowlpox virus (rFPV)
vectors expressing NP andM1 transgenes from avian influenza
A/Turkey/Turkey/1/2005 (H5N1) or GFP were the kind gift of
Dr. Mike Skinner (Imperial College). Modified Vaccinia Ankara
(MVA) virus expressing a fusion protein of nucleoprotein and
matrix protein 1 (MVA-NpM1) from influenza A/Panama/2007/
99 (H3N2)was supplied by the Vector Core Facility at the Jenner
Institute (Oxford, UK) (Berthoud et al., 2011).2.3. Vaccination and infection
In a first round of experiments, 3 week old birds were
randomly allocated to infected or control groups. Birds were
challenged by intranasal inoculation of LPAI (A/Turkey/
England/1977 H7N7) at a dose of 3.4×107 pfu in 100 μl PBS
per bird. In the second round of experiments, birds were
vaccinated subcutaneously with 105 pfu rFPV at 1 day old,
boosted with the same dose at 9 days old, and challenged
with LPAI, as above, at 4 weeks old. Birds were killed 10 days
post-infection.
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Sterile polyester tipped swabs (Fisher Scientific, UK) were
used to sample buccal cavities, transferred to a solution of viral
transportmedia (WorldHealthOrganization. Dept. of Epidemic
and Pandemic Alert and Response., 2002), vortexed briefly,
clarified of debris by centrifugation at 450 ×g for 2 min and
stored at –80 °C. RNA was extracted using the QIAamp One-
For-All Nucleic Acid Kit on an automated extraction platform
(Qiagen BioRobot Universal System, Qiagen, UK) according to
themanufacturer's instructions. Quantitation of influenza virus
in RNA from swabs was performed by analysis of matrix gene
transcripts. A single step real-time reverse transcriptase PCR
was carried out using the Superscript III Platinum One-Step
qRT-PCR Kit (Life Technologies, UK). Primers and a probe
specific for a conserved region of the Influenza A Matrix gene
were used as described previously (Spackman et al., 2002).
Cycling conditions were: 50 °C, 5 min; 95 °C, 2 min; and then
40 cycles of 95 °C, 3 s and 60 °C, 30 s, using a 7500 fast real-
time PCR machine (Applied Biosystems, UK). Results are
expressed in terms of the threshold cycle value (Ct), the cycle
at which the change in the reporter dye signal passes a sig-
nificance threshold (Rn).
2.5. Cell lines
MDCK cells were grown in Dulbecco's Modified Eagles
Medium (DMEM) with Glutamax (Life Technologies), supple-
mented with non-essential Amino Acids (Sigma), 100 U/ml
penicillin, 100 μg/ml streptomycin and 10% fetal bovine serum
(FCS). Chinese hamster ovary (CHO) cells were grown in Ham's
F12 medium (Life Technologies) with 10% FCS. Puromycin HCl
(Enzo) was used at 20 μg/ml for selection of IFNγ transfected
lines and at 15 μg/ml for maintenance of transfected CHO cells.
Cell cultures were maintained in 5% CO2 at 37 °C.
Primary chicken kidney cell (CKC) lines were established
from10 day old birds following guidelines previously described
(Seo and Collisson, 1997). Briefly, cells were dispersed with
trypsin digestion and cultured in 150 or 75 cm2 tissue culture
flasks. The CKC adherent cells were continuously cultured by
passage every 4–6 days in Minimum Essential Medium (MEM)
supplemented with tryptose phosphate broth (TPB), gluta-
mine, 1M HEPES, fungizone, 100 U/ml penicillin, 100 μg/ml
streptomycin and 10% FCS. Chicken cell cultures were main-
tained in 5% CO2 at 41 °C.
2.6. Generation of anti-chicken IFNγmonoclonal antibodies
Antibodies were generated using a technique previously
described (Staines et al., 2013). Briefly, chicken IFNγ was
amplified from a spleen cDNA library using the following
primers; IFN-Foward-NheI (5′-AGCCATCAGCTAGCAGATGAC
TTG) and IFN-Reverse-BglII (5′-ATCTCCTCAGATCTTGGCTCCTT
TTC) and cloned into an Ig-fusion protein vector. To obtain
ChIFNγ monoclonal antibodies, we immunized mice with two
intramuscular injections of 100 μg of the IFNγ-IgG1Fc plasmid
diluted in PBS (endotoxin free, Qiagen Endofree Plasmid
Maxi Kit) at four week intervals. After a further four weeks,
mice received a final boost with an intraperitoneal injection
of 50 μg purified fusion protein and were sacrificed four days
later for preparation of splenocytes whichwere fusedwith NS0hybridoma partner cells using established methods. Hybrid-
oma supernatants were first screened by ELISA for antibodies
binding fusion protein immobilized with anti-human IgG and
detectedwith HRP conjugated goat anti-mouse IgG. Antibodies
recognizing the human Ig moiety of the fusion protein were
eliminated by a similar ELISA using a control fusion protein
containing the same human IgG1 sequence (DEC205-IgG1Fc,
(Staines et al., 2013)). Antibodies from two IFNγ-specific
clones, AF10 and EH9, were purified from high density culture
(miniPERM, Sarstedt) with Hi Trap Protein G HP columns
(Amersham-Pharmacia, UK) according to the manufacturer's
instructions. After dialysis against PBS, the concentration of
these antibodies was estimated by measurement of the absor-
bance at 280 nm.
2.7. Preparation of infected CKC
CKC were infected with A/Turkey/England/1977/H7N7 for
use in co-culture as previously described (Singh et al., 2010a).
Briefly, confluent monolayers of CKC (after a minimum of
8 passages) were infected with AIVs for 1 h at a Multiplicity of
Infection (MOI) of 3–5, washed with PBS, and incubated for
4 h with CKC growth media without FCS, supplemented with
TPCK trypsin (Sigma). Cells were then washed, dispersed with
trypsin, washed again, counted, resuspended in leukocyte cul-
turemedia and then irradiatedwith 3000 rad using aGammacell
1000 Elite caesium 137 gamma irradiator (Nordion, Canada).
For infectionwith recombinantMVA, CKCswere infected by
incubation for 1 h at 37 °C at an MOI of 5. We optimized these
conditions through analysis of GFP transgene expression by
confocal microscopy (Supplementary Fig. 1). Following incu-
bation, cellswerewashed, counted, irradiated as described, and
resuspended in leukocyte culture media. The irradiated CKC
were used at a ratio of 1:10 (CKC:splenocyte) in co-culture
ELISpot.
For confocal imaging 5×104 primary CKC in growth media
per chamber of an 8 chamber slide (Lab-TekII, Nunc) were
incubated at 41 °C, 5% CO2, for 1 day. Any non-adherent cells
were discarded and the adherent cell population was infected
with MVA-GFP constructs as described above. After incubation,
cells were fixed with a solution of 4% paraformaldehyde for
20 min, and then washed in PBS. Nuclei were stained by incu-
bation with 2 μg/ml DAPI (Sigma) for 10 min. Sections were
mounted in Vectashield (Vector Laboratories) and analyzed
using a confocal microscope (Leica SP2 with 405-, 488-, and
568-nm lasers).
2.8. IFNγ ELISpot
Spleens were macerated in cold sterile PBS and passed
through a 100 μm cell strainer (Fisher, UK). Cell suspensions
were centrifuged at 220×g for 10min at 4 °C and resuspended
in culture media (RPMI 1640 medium with Glutamax supple-
mented with 10% FCS, 100 U/ml penicillin, and 100 μg/ml
streptomycin) (all from Life Technologies, UK) before under-
laying Histopaque 1119 (Sigma, UK) and centrifuged at
2000 rpm (492 ×g) for 20 min at 4 °C. Cells harvested from
the interphasewere washed twice, counted using a Countess™
automated cell counter (Life Technologies) and resuspended
at 5 × 106/ml. ChIFNγ ELISpot was carried out as described
previously (Ariaans et al., 2008), using either antibodies from a
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(chicken IFNγ ELISA kit, Life Technologies ®) or EH9/AF10
antibodies produced as described. 96-well plates (MAIPS4510,
Millipore) were coated overnight at 4 °C with the commercial
capture antibody or EH9, diluted in pH 9.6 50 mM carbonate/
bicarbonate buffer at a final concentration of 2 μg/ml, and
washed with PBS +0.1% Tween 20 at this stage and between
all subsequent steps. Plates were blocked with experiment
culture media. Chicken leukocyte suspensions consisting of
3 or 5 × 105 cell/well were maintained in 5% CO2 at 41 °C for 1
or 2 days. Cells were incubated in the presence of either
culture medium or medium supplemented with one of the
following stimuli to a final volume of 200 μl per well: phorbol
12-myristate 13-acetate (PMA 500 ng/ml) plus ionomycin
(750 ng/ml, Sigma); Concanavalin A (ConA, 10 μg/ml final;
Sigma); inactivated or live virus (MOI 3-5); prepared exoge-
nous APCs (1:10, CKC: splenocyte), pooled or individual
peptide (5 μM). A library of 62 overlapping peptides spanning
NP protein from A/Turkey/England/1977/H7N7 virus (chal-
lenge virus) was synthesized commercially (Neobioscience,
Massachusetts, USA), resuspended in DMSO or in a solution
of 50% acetic acid in water, aliquots stored at −20 °C until
use, and then diluted to a final concentration of 5 μM in cul-
ture wells. Peptides were 18 aa long and 10 aa overlapping
(Supplementary Table 1). When the chicken IFNγ ELISA kit
(Life Technologies®) was used, ELISpot plates were then incu-
bated at RT with the biotinylated detection antibody (1 μg/ml)
followed by an incubation with streptavidin-horseradish per-
oxidase conjugate at a 1/2000 dilution. Otherwise plates were
incubated with the detection antibody AF10, followed by an
incubation with first a biotinylated goat anti-mouse anti
isotype IgG2b (AF10 isotype) antibody (Southern biotech)
followed by avidin-HRP (Southern Biotech). Plates were
developed by incubation with 100 μl per well of 3-amino-9-
ethylcarbazole, (AEC, Merck Chemicals, UK). After spot devel-
opment, plates were rinsed with tap water and allowed to
dry overnight before counting using an ELISpot plate reader
(AID systems, Germany). Results were expressed as number of
spots (SFU, spot forming unit) per 106 splenocytes. Depending
on the stimuli used, experiments were carried out in triplicate
(whole virus or CKCs) or in duplicate (peptides).
2.9. Serum sample processing and hemagglutination
inhibition assays
Blood samples (0.5–1 ml/bird) from all challenged birds
were drawn fromawing vein 2 weeks after infection to evaluate
humoral responses against influenza virus. These were left to
clot at room temperature (RT) and sera were retrieved after
centrifugation and stored at−20 °C until analysis. A standardHI
test was used tomeasure serumAIV antibody titers, whichwere
expressed in log2 mean HI titers in each sample for each group
(Spackman, 2008).
2.10. Flow cytometry and intracellular staining of ChIFNγ
Cultured cells were resuspended in U bottom 96-well plates
in FACS buffer (PBS containing 1.0% BSA and 0.1% sodium
azide) and incubated with normal mouse serum (1%) for
10min at RT to block non-specific binding. For surface staining,
cells were incubated, protected from light, for 15 min at roomtemperature with appropriate dilutions of antibodies: mouse
anti-chicken CD4-FITC (CT4) (Southern Biotech), CD8α-PerCp
(Tregaskes et al., 1995). After incubation, cells were washed
twice with FACS buffer and were either used for intracellular
staining or fixed with a solution of 2% paraformaldehyde in
PBS. Incubationwith primary antibodies toMHC I (Salomonsen
et al., 1987) andMHC II (Kaufman et al., 1990) was followed by
Alexa-647 conjugated goat anti-mouse antibody (Life Technol-
ogies). Secondary antibody alone or unconjugated goat anti-
mouse antibody (Life Technologies) was used as an unstained
control for surface MHC staining. Intracellular staining was
carried out as described previously (Ariaans et al., 2008).
Briefly, splenocytes from challenged birds or non-infected
controls were seeded in a 96-well round-bottom plates
(Nunc) at 106 cells/well in a final volume of 200 μl of culture
media or culture media supplemented with the different
stimuli at the concentration described in the ELISpot tech-
nique (except PMA which was used at 50 ng/ml). Cells were
cultured using the conditions described above for ELISpot
assays (24 h culture). For intracellular staining, during the last
2 h of culture, cells were treated with Brefeldin A according
to the manufacturer's instructions (Cytofix/Cytoperm™ Plus
Fixation/Permeabilization kit, BD Biosciences). To avoid non-
specific binding signal, we preincubated cells with Cytofix/
Cytoperm™ buffer containing 2% normal mouse serum and
further staining steps involved Cytofix/Cytoperm™ washing
buffer containing 1% normal mouse serum (Biosource). To
confirm the specificity of the anti-IFNγ antibody EH9 we also
employed a validated anti-IFNγ [mAb80 (Ariaans et al., 2008)].
Purified fractions of both antibodies were conjugated using
Alexa Fluor® 647 monoclonal antibody labeling kit (Molecular
Probes) according to the manufacturer's instructions. A mouse
isotype matched control antibody IgG1 Alexa Fluor® 647 (Life
Technologies) was employed at the same concentration as
EH9 and Mab80. For analysis, a gate on the FSC/SSC region of
lymphocytes was selected and a minimum of 10,000 events
were acquired on a FACSCalibur instrument using Cell Quest
software (BD Becton Dickinson). Flow cytometry analysis indi-
cates that non-adherent CKC were not present at significant
levels (data not shown). FlowJo software (TreeStar) was used
to analyze flow cytometry data.
2.11. Statistical analysis
A paired or unpaired t-student test or one-way ANOVAwas
performed using GraphPad Prism (version 6.0 for Windows,
GraphPad Software, San Diego, California, USA).
3. Results
3.1. Validation of anti-chicken interferon gamma antibodies
Screening identified two anti-chicken IFNγ antibodies
(clones EH9 and AF10) which were shown by ELISA to bind
recombinant chicken IFNγ and to work effectively as an anti-
body pair in capture ELISA (Supplementary Fig. 2A–C). We
subsequently compared this antibody pair with commercially
available antibodies [from Life Technologies (Ariaans et al.,
2008; Reemers et al., 2012)] in ELISpot assays. There were
no differences in the numbers of spots from the same samples
of chicken splenocytes stimulated with Con A using either
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Technologies: 338.9 ± 21.3 SFU/106 cells, n = 9 (Supplemen-
tary Fig. 2D)).
3.2. Viral shedding dynamics and immune responses
Following intranasal infection of Line O birds with LPAI
H7N7, buccal swab samples were analyzed for the presence
of influenza M1 transcript by qRT-PCR. These were found to
be positive from the earliest sampling time point at day 4 post-
infection. Viral transcriptwas still detectable albeit at a lower level
(p b 0.05) in the buccal swabs at day 6, and was undetectable
at day 10 (data not shown). Challenged birds exhibited
significantly higher HI titers compared to non-infected controls
(Fig. 1A, p b 0.01). All subsequent experiments were per-
formed in LineO birds, with the exception of the vaccine cohort
(Line 15, final figure).
We tested our antibody pair for use in ELISpot with live or
beta propiolactone inactivated challenge-strain virus to stim-
ulate splenocyte responses (Fig. 1B). Splenocytes from control
(non-infected) birds did not produce IFNγ when exposed to
either live or inactivated virus. In contrast, splenocytes fromFig. 1. Viral shedding, serum antibody titers and ELISpot responses of challenged b
A) Influenza antiserum titers, HI assay from non-infected birds and infected birds; resu
of splenocytes from infected birds (INF, n = 4) sacrificed 2 weeks after challenge and
virus (AIVInact) and live virus (AIVLive). Results expressed asmean (±S.E.M.) of spot for
* = p b 0.05, ** = p b 0.01. SFU: spot forming units. C) ChIFNγ ELISpot responses of
peptides were analyzed in splenocytes from individual birds infected at 2 weeks post-infected birds did produce IFNγ (p b 0.05) following exposure
to both live (72.0 ± 15.4 SFU/106 cells) and inactivated virus
(155.2 ± 42.3 SFU/106 cells), as expected. The use of live virus
consistently yielded lower responses than the use of inactivated
virus in all samples, although this differencewas not statistically
significant.
To identify epitope-specific responses, we employed an
NP peptide library corresponding to the challenge virus. We
analyzed responses to pooled peptides at 1week post-infection
(Supplementary Fig. 3) and to individual peptides 2 weeks
after infection (Fig. 1C). Responses to individual peptides were
low, not consistent between birds, and not statistically signif-
icantly different between control and infected birds. In the
following experiments, an alternative strategy to detect specific
IFN responses was developed.
3.3. CKCs express only MHC class I following repeated passage
To potentiate the detection of influenza-specific CD8 T cell
responses, we generated a CKC cell line expressing only MHC
class I. We passaged CKC from Line O birds a minimum of eight
times. We then analyzed the cells by flow cytometry for theirds. Birds were challenged with LPAI influenza strain H7N7/turkey/Eng/77.
lts expressed asmean± S.E.M. (n= 6 per group). B) ChIFNγ ELISpot responses
non-infected birds (non-INF, n = 3) were cultured with neutralized influenza
ming units (SFU) per million cells. Significance of data is represented as follows:
peptide library against influenza viral nucleoprotein (NP). In total, 62 different
challenge (black dot, n = 3) and control not infected (white circle, n = 1).
Fig. 3. Splenocyte IFNγ co-culture ELISpot responses to infected CKC. Splenocytes
from infected birds (INF, n = 4) sacrificed 2 weeks after challenge and control
non-infected birds (non-INF, n = 3) were cultured with infected chicken kidney
cells (CKCINF). Results expressed as mean (±S.E.M.) of spot forming units (SFU)
per million cells. Significance of the data is represented as follows: * = p b 0.05,
** = p b 0.01. SFU: spot forming units.
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found to exclusively express MHC class I (Fig. 2).
3.4. ELISpot using infected CKC co-culture method
Having validated the necessary individual components we
introduced the method of co-culture of responding cells with
infected CKCs. Despite the fact that so many antigen specific
cells were detectable in co-culture with infected CKCs, the
background response for this assaywas extremely low (control
and INFγ only data, Fig. 3), demonstrating its specificity and
sensitivity. Splenocytes from infected birds (2 weeks post-
infection) produced extremely high (mean: 833 ± 134 SFU/
106 cells) numbers of spot forming units when co-cultured
with infected CKC (Fig. 3). This response was significantly
different (p b 0.01) from the response seen with infected CKC
co-cultured with splenocytes from non-infected (control) birds.
The SFU count seenwith co-culture of infected CKCwith infected
splenocytes was close to that seen with cells from infected birds
stimulated with PMA/ionomycin (1060 ± 53 SPU/106 cells),
suggesting that antigen specific antiviral IFNγ producing cells
constitute the majority of those able to rapidly produce IFNγ.
It was interesting to note that splenocytes from infected birds
have greater SFU responses to PMA in our study (discussed
below).
3.5. Analysis of IFNγ positive cells from co-culture assay
To analyze the phenotype of the responding splenocytes
from infected birds we performed intracellular staining on
cells from co-culture assays. We first validated antibody (EH9)
against a previously published anti IFNγ antibody (mAb80,
(Ariaans et al., 2008)) using IFNγ transfected CHO cell lines
(Supplementary Fig. 4) and in splenocytes stimulated with
PMA/ionomycin (Fig. 4A). There was no statistically significant
difference between results obtained with the two antibodies.
Non-specific signalwasnot detected by isotype control staining
(Fig. 4B).Fig. 2.Analysis ofMHC class I and II expression on CKC passaged at least 8 times.
Expression of MHC classes I and II on CKC detected using an Alexa 647 labeled
secondary antibody. Dark line = class II, dark gray line = class I, light gray
line = unlabelled secondary antibody, dashed line = only Alexa 647 labeled
secondary antibody.We then analyzed the phenotype of IFNγ expressing cells
from infected birds, following co-culturewith either infected or
non-infected CKC. Data shown are for a representative sample
from infected and non-infected birds (Fig. 4C) gating in the
same FSC/SSC lymphocyte region (Fig. 4A) for all conditions.
The greatest number of interferon gamma producing cells was
detected during co-culture of infected CKC with splenocytes
from infected birds (0.517%), compared with splenocytes from
infected birds co-culturedwith non-infected CKC (0.069%), and
splenocytes from non-infected birds co-cultured with infected
CKC (0.071%). It is important to note that the majority of IFNγ
positive splenocytes from infected birds co-cultured with
infected CKC were CD8 positive (N60%, Fig. 4C).
3.6. Detection of antigen speciﬁc IFNγ responses in splenocytes
from recombinant Fowlpox vaccinated birds employing CKC
infected with recombinant virus MVAGFP/MVANpM1 after
inﬂuenza challenge
Having established the utility of the co-culture ELISpot
we used the technique to analyze influenza antigen specific
responses in birds vaccinated (prime and boost) with recombi-
nant Fowlpox (F9) or recombinant Fowlpox-NpM1 (F9-NpM1),
and then challenged with an influenza virus with heterologous
nucleoprotein and matrix protein. Instead of infecting the CKC
with influenza virus we used recombinant MVA carrying either
a GFP or NpM1 fusion transgene (homologous to the Fowlpox
recombinant) then irradiated the infected CKC as described.
Three of the four F9-NpM1 vaccinated birds challengedwith
influenza showed IFNγ responses that distinguished them from
F9 vaccinated and challenged birds (Fig. 5) (40.0 ± 12.5 vs.
3.0 ± 1.9, p b 0.05). The majority of responses in the F9-NpM1
vaccinated birds were greater with CKC infected with MVA-
NpM1 fusion transgene. Some responses were also observed
with F9-NpM1 vaccinated birds when APCs were infected with
MVA-GFP (although this result was not significant). Our results
with vaccinated birds thus suggest that this technique can be
used to evaluate vaccine induced responses, and additionally
that recombinant viruses expressing appropriate transgenes
Fig. 4. Intracellular IFNγ staining and phenotype of responding lymphocytes following co-culture. A) Representative example of gating of live lymphocytes in
intracellular staining. Lymphocyte gate was designated for the region of lymphocytes stimulated with PMA/Io (bottom left figure) and applied to other culture
conditions (media alone, upper left figure). B) Comparison of EH9 (in house) andmAb80 (previously described) intracellular staining for IFNγ; both antibodies detected
a similar percentage of IFNγ+ cells in media control or PMA/ionomycin stimulated splenocytes. Matched IgG isotype control was also employed. C) Representative
example of intracellular staining of CKC co-cultured with splenocytes from an infected bird (BIRDINF) or control non-infected bird (BIRDNON-INF): upper row figures,
percentage of IFNγ positive cells following co-culture with non-infected (CKCnon-Inf) or infected (CKCInf) CKC; lower row figures, CD4+ and CD8+ lymphocyte
populations in the IFNγ positive populations from above figures.
46 R. Ruiz-Hernandez et al. / Journal of Immunological Methods 416 (2015) 40–48can be used to replace influenza infection of CKC. This permits
the analysis of more defined antigen specific responses while
reducing the requirement to handle live influenza virus in the
laboratory.
4. Discussion
Wehavedeveloped amethod topotentiate the detection and
analysis of influenza antigen specific T cells utilizing infected CKCFig. 5. IFNγ co-culture ELISpot using CKC infected with recombinant MVA and
splenocytes from birds challenged with LPAI. ELISpot responses in splenocytes
from infected birds from unvaccinated (PBS group, n = 3) or birds vaccinated
with a recombinant vaccine Fowlpox (F9 group, n = 4), or FowlpoxNpM1
(F9-NpM1 group, n = 4). Splenocytes were cultured with either irradiated
MVAGFP infected CKC (black dot) or irradiatedMVANpM1 (white circle) infected
CKC. Lines indicate samples from the same spleen under the two previous
conditions. Resultswere expressed as spot formingunits (SFU)permillion cells.
Significance of the data is represented as follows: * = p b 0.05.to present viral peptides in amanner biologically relevant to CD8
T cells. We have demonstrated that our co-culture ELISpot
detects greater numbers of antigen specific CD8 T cells than
ELISpot with whole virus as an antigen. Our assay can also be
adapted to use recombinant viruses to infect CKC, increasing its
specificity and reducing the requirement to work with live
influenza virus. Our results are the first to demonstrate detection
by flow cytometry of influenza-specific IFNγ responses in in-
dividual T cells from LPAI infected birds.
The ability of our method to detect such large numbers of
antigen specific T cells (similar numbers to positive controls
with PMA/ionomycin, see example Supplementary Fig. 5) likely
reflects not only the high promiscuity of the B21 haplotype, but
also the fact that our CKC cell line expresses only MHC class I
and presents peptides following a biologically relevant infec-
tion process.
In ELISpot using whole influenza virus we were able to
detect antigen specific responses, although these were much
lower (Fig. 1). Although ELISpot has previously been used
to measure antiviral responses against other avian viruses,
including NDV (Ariaans et al., 2008) and IBV (Ariaans et al.,
2009), it has never been employed to analyze avian responses
to influenza. In the present study, following challenge with
H7N7 LPAI, the birds became serologically positive and showed
specific IFNγ responses, irrespective of whether inactivated or
live avian influenza virus was added to endogenous APCs
(Fig. 1). Additionally, ELISpot with live virus added to sple-
nocytes from infected birds further reduced SFU counts. It
is possible that live virus affects the interactions, and/or the
functionality, of cells in vitro (Hinshaw et al., 1994; Oh et al.,
2000; Hao et al., 2008).
47R. Ruiz-Hernandez et al. / Journal of Immunological Methods 416 (2015) 40–48It was interesting to note that splenocytes from infected
birds have greater SFU responses to PMA in our study. PMA
does not activate all T cells (Suzawa et al., 1984; Kim et al.,
1986)., It may be that antigen experienced cells (from infected
birds) have a lower threshold of activation and are activated
more readily by PMA, hence the higher SFU counts in the
infected cohort positive control compared with the non-
infected. Another possibility is altered lymphocyte subset
frequencies in infected birds. We did not note any difference
in the relative proportions of B and T lymphocytes between
infected and non-infected birds (data not shown) but as
detailed analysis of T cell subsetswas not performedwe cannot
discount a greater frequency of a subset more responsive
to PMA in the infected birds. Given the magnitude of the
difference we consider this second possibility less likely. Un-
fortunately given the paucity of this type of data in this area in
avian immunology we have not been able to make extensive
direct comparisons, other than to observe that our positive
control results are in the range reported by the few directly
comparable studies of ELISpot and/or intracellular staining
(Ariaans et al., 2008, 2009); however these do not report
directly comparable infection data. In the only study regarding
the phenotype of responding cells during HPAI infection of
chickens (Seo et al, 2002), employing different methods, the
percentage of IFNγ producing CD8 positive cells in the spleen
was approximately 50% at day 6 post-infection, falling to an
average of 15% at 20 days post-infection. This result is much
higher than that detected in infected birds in our study;
however Seo et al. did not distinguish between IFNγ producing
T cells and IFNγ from NK cells, which may account for the
difference.We could detect no evidence for NK activation using
our method as we were not able to detect a significant number
of IFNγ positive cells with splenocytes from non-infected
birds cultured with infected CKC (Fig. 4C), or with splenocytes
from infected birds cultured with non-infected CKCs (Supple-
mentary Fig. 5). While our study did not identify the TCR
subtype of the IFNγ producing CD8 positive cells, it has been
hypothesized that the main population involved in IFNγ
responses and in viral clearance is TCR αβ (Vβ1, TCR2) (Seo
et al., 2002). Interestingly, the control of acute IBV infection
has also been attributed to CD8-TCR2 lymphocytes (Collisson
et al., 2000). Further studies are required to identify the TCR
subsets responsible for the immune response in our model.
Our co-culture method was better able to distinguish
responses between infected and control birds than ELISpot
using a peptide library. In comparison with recently published
work using a high concentration of peptides to analyze
influenza-specific responses (Reemers et al., 2012), the co-
culture ELISpot is more sensitive and has a significantly lower
background. However unlike peptide assays, it lacks precise
epitope specificity and cannot distinguish responses against
individual proteins. We demonstrated a further level of spec-
ificity by infecting CKC with an MVA recombinant virus
expressing a fusion protein (NpM1) from a human H3N2
virus (Berthoud et al., 2011). These cells were used to present
antigens to splenocytes from birds given a recombinant
Fowlpox vaccine, also expressing nucleoprotein and matrix
protein 1, and then challenged with a heterologous LPAI
virus. Although the NpM1 sequences of the MVA, Fowlpox
recombinants and challenge virus were not homologous, these
are highly conserved (Lillie et al., 2012) internal influenzaantigens (example 98% homology for NP and 100% for M1
protein, Supplementary Fig. 6). We have already shown cross
protective immune responses using the MVA vector and the
same strain of influenza virus (Boyd et al., 2012). In the current
study, we were able to distinguish if individual infected birds
were vaccinated or not, since the vaccinated group possessed
higher specific responses than unvaccinated birds. Our results
suggest that infection of CKC with recombinant virus contain-
ing transgenes for an epitope of interest could be used to
increase the sensitivity of assays to detect antigen and epitope
specific T cells.
In summary we have developed a sensitive method for
the detection of antigen specific T cells,whichwill be important
in the analysis of immune responses to both vaccines and
pathogens. The assay provides greater sensitivity than the
use of inactivated or live virus in ELISpot, and reduced back-
ground compared with peptide library ELISpot. Our method
is also more accessible to a wider community than methods
employing expensive peptide libraries, the interpretation of
which data is rendered problematic due to an incomplete
knowledge of avian MHC binding specificities. While we have
demonstrated its efficacy for influenza, this technique can
be applied to the study of T cell responses for many avian
pathogens. We also demonstrated that the use of recombinant
virus to infect CKC can further define antigen specificity, and
additionally reduce the requirement to handle live zoonotic
pathogen, an important safety consideration.
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